American Healthcare REIT Analyst Price Targets

Wall Street analyst price targets and consensus rating for American Healthcare REIT (AHR).

Price Target Range — 12 Quarters

Analyst Consensus — 16 Analysts

4S.Buy

12Buy

Consensus RatingBuy# Analysts16Avg. Consensus PT$50Upside to Avg. PT-7.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	UBS	Michael Goldsmith	PT Cut	Buy	$63→$62
Oct 13, 2026	Barclays	Richard Hightower	PT Cut	Overweight	$66→$60
Oct 13, 2026	Raymond James	David Rodgers	Initiate	Strong Buy	$62
Sep 2, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$56→$62
Aug 31, 2026	Barclays	Richard Hightower	PT Raise	Overweight	$61→$66
Aug 19, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$58→$68
Aug 14, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$57→$61
Aug 14, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$56→$61
Aug 13, 2026	Citigroup	Nick Joseph	PT Raise	Buy	$55→$65
Jul 27, 2026	Citizens	Aaron Hecht	PT Raise	Market Outperform	$60→$65
Jul 21, 2026	Compass Point	Rob Simone	Initiate	Buy	$70
Jul 8, 2026	UBS	Michael Goldsmith	PT Raise	Buy	$60→$63
Jul 7, 2026	Barclays	Richard Hightower	Initiate	Overweight	$61
Jun 23, 2026	Citigroup	Nick Joseph	Upgrade	Neutral→Buy	$55
Jun 18, 2026	Scotiabank	Nicholas Yulico	PT Cut	Sector Outperform	$59→$51
May 28, 2026	Keybanc	Austin Wurschmidt	PT Raise	Overweight	$55→$58
May 26, 2026	RBC Capital	Michael Carroll	PT Raise	Outperform	$54→$56
Mar 13, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$52→$57
Mar 11, 2026	Scotiabank	Nicholas Yulico	PT Raise	Sector Outperform	$55→$59
Mar 2, 2026	Citigroup	Nick Joseph	PT Raise	Neutral	$52→$55

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $63 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.

Benzinga Newsdesk

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).

Avi Kapoor

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

Raymond James analyst David Rodgers initiates coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and announces Price Target of $62.

Benzinga Newsdesk

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and raises the price target from $56 to $62.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.

Benzinga Newsdesk

American Healthcare REIT Inc

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

People Also Watch

People Also Watch

American Healthcare REIT Inc

American Healthcare REIT Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRORaymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PROScotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PROBarclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60

PRO
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62

PRO
Scotiabank Maintains Sector Outperform on American Healthcare REIT, Raises Price Target to $62

PRO
Barclays Maintains Overweight on American Healthcare REIT, Raises Price Target to $66